HYPER-MASTIC research project, coordinated by IASIS PHARMA and involving reputable academics and corporations, is looking for hypertensive patients to participate in an Inter-University Study, under the auspices of the EU. For further information concerning HYPER-MASTIC, visit the website www.hyper-mastic.eu and Facebook page: Hyper-Mastic
PRESS RELEASE FOR THE INITIATION OF A CLINICAL STUDY ON THE EFFECT OF CHIOS MASTIC ON BLOOD VESSELS’ FUNCTIONALITY AND INFLAMMATION
IASIS PHARMA proudly announces the exclusive sponsorship of a clinical trial on the effect of Chios Mastic on blood vessels’ functionality and inflammation”. The research center conducting the study is “Alexandra” General Hospital, the results of the study are expected to be announced the last quarter of 2016.
PRESS RELEASE FOR THE INITIATION OF A CLINICAL STUDY ON THE EFFECT OF MASTIHATHERAPY CAPS ON HELICOBACTER PYLORI
IASIS PHARMA proudly announces the exclusive sponsorship of a clinical trial on the effect of Chios Mastic in capsules on Helicobacter Pylori. The main research center is “Laiko” Hospital of Athens. Read more about the study's latest findings here